Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
International Journal of Cancer|October 12, 2012
Hypoxia-inducible factors as key regulators of tumor inflammationSoulafa Mamlouk, Ben WielockxBioinformatics (Oxford, England)|May 18, 2016
SoFIA: a data integration framework for annotating high-throughput datasetsLiam Harold Childs, Soulafa Mamlouk, Jörgen Brandt, et al.Scientific Reports|January 25, 2019
Robust in-silico identification of Cancer Cell Lines based on RNA and targeted DNA sequencing dataRaik Otto, Jan-Niklas Rössler, Christine Sers, et al.Cancer Genomics & Proteomics|January 22, 2008
Irradiated breast cancer patients demonstrate subgroup-specific regularities in protein expression patterns of circulating leukocytesKristina Yeghiazaryan, Soulafa Mamlouk, Daniela Trog, et al.International Journal of Cancer|August 6, 2013
Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor developmentSoulafa Mamlouk, Joanna Kalucka, Rashim Pal Singh, et al.BMC Cancer|October 29, 2020
The majority of β-catenin mutations in colorectal cancer is homozygousAlexander Arnold, Moritz Tronser, Christine Sers, et al.BMC Cancer|November 27, 2020
Correction to: The majority of β-catenin mutations in colorectal cancer is homozygousAlexander Arnold, Moritz Tronser, Christine Sers, et al.Cancer Research|March 26, 2011
Inhibition of HIF prolyl hydroxylase-2 blocks tumor growth in mice through the antiproliferative activity of TGFβAnne Klotzsche-von Ameln, Antje Muschter, Soulafa Mamlouk, et al.BMC Biology|September 8, 2020
Malignant transformation and genetic alterations are uncoupled in early colorectal cancer progressionSoulafa Mamlouk, Tincy Simon, Laura Tomás, et al.Molecular and Cellular Biology|June 27, 2013
Loss of epithelial hypoxia-inducible factor prolyl hydroxylase 2 accelerates skin wound healing in miceJoanna Kalucka, Andreas Ettinger, Kristin Franke, et al.Pageof 3